marginal significancep = 0.06
We found that the patients with the top 20% UBE2L3 expression levels showed a marginal significance with a higher risk of worse prognosis compared to the rest (HR: 4.16 [95% CI: 0.92–18.77], p = 0.06; log-rank test: p = 0.04, Fig. 2 c).